Hematologic values of the FA patients at the time of the study
UPN . | Age, y, sex . | Complementation group . | WBC count, × 103/μL . | PMN count, × 103/μL . | Hb level, g/dL . | Platelet count, × 103/μL . | BM cellularity, % . | BM cytogenetics . |
|---|---|---|---|---|---|---|---|---|
| 1 | 6, F | A | 4.000 | .920 | 12.3 | 41 | 30 | 46,XX |
| 2 | 16, F | ND | 4.500 | 2.025 | 11.8 | 75 | ND | 46,XX |
| 3 | 5, F | A | 8.500 | 2.100 | 10.7 | 56 | ND | 46,XX |
| 4 | 12, F | ND | 3.215 | .870 | 9.6 | 47 | ND | 46,XX11q- |
| 5 | 2, F | A | 7.500 | 2.700 | 11.8 | 198 | ND | 46,XX |
| 6 | 8, F | A | 3.800 | .360 | 8.3 | 18 | <20 | 46,XX |
| 7 | 14, M | C | 3.500 | 2.000 | 14.4 | 125 | ND | 46,XY |
UPN . | Age, y, sex . | Complementation group . | WBC count, × 103/μL . | PMN count, × 103/μL . | Hb level, g/dL . | Platelet count, × 103/μL . | BM cellularity, % . | BM cytogenetics . |
|---|---|---|---|---|---|---|---|---|
| 1 | 6, F | A | 4.000 | .920 | 12.3 | 41 | 30 | 46,XX |
| 2 | 16, F | ND | 4.500 | 2.025 | 11.8 | 75 | ND | 46,XX |
| 3 | 5, F | A | 8.500 | 2.100 | 10.7 | 56 | ND | 46,XX |
| 4 | 12, F | ND | 3.215 | .870 | 9.6 | 47 | ND | 46,XX11q- |
| 5 | 2, F | A | 7.500 | 2.700 | 11.8 | 198 | ND | 46,XX |
| 6 | 8, F | A | 3.800 | .360 | 8.3 | 18 | <20 | 46,XX |
| 7 | 14, M | C | 3.500 | 2.000 | 14.4 | 125 | ND | 46,XY |
ND indicates not determined.